HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myocardial stunning after coronary bypass surgery.

Abstract
At the Toronto Hospital, 2,510 patients received isolated coronary bypass grafts (CABG). Overall mortality was 2.3%, the incidence of low output syndrome (as defined by need for inotropic agents or intraaortic balloon pump) was 9.2%, and mortality among low output syndrome patients was 16%. We have attempted to identify factors that minimize cardiac injury. We have previously shown that free radical injury occurs during CABG: coronary blood contains increased levels of conjugated dienes after cross-clamp release; and, there is a reduction in the antioxidant, alpha-tocopherol. In vitro studies revealed that ascorbic acid and alpha-tocopherol protect cardiac myocytes, while endothelial cells are protected from free radical injury by superoxide dismutase and catalase. To test the former two antioxidants in vivo, we used left anterior descending artery (LAD) occlusion in the dog followed by 2 to 4 hours of reperfusion. When administered in deoxygenated saline at 30 seconds prior to reperfusion and 4 minutes after release of LAD occlusion, both agents significantly reduced the infarction area compared to simple reperfusion or deoxygenated saline alone. Antioxidants therefore have the potential to reduce the ischemic injury and myocardial stunning that accompany CABG.
AuthorsR D Weisel
JournalJournal of cardiac surgery (J Card Surg) Vol. 8 Issue 2 Suppl Pg. 242-4 (Mar 1993) ISSN: 0886-0440 [Print] United States
PMID8461512 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Free Radicals
Topics
  • Animals
  • Antioxidants (therapeutic use)
  • Cardiac Output, Low (etiology)
  • Cardiomyopathies (etiology, physiopathology, prevention & control)
  • Coronary Artery Bypass (adverse effects, methods)
  • Dogs
  • Free Radicals (adverse effects)
  • Humans
  • Myocardial Reperfusion
  • Ventricular Function, Left (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: